Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people starting Wegovy ask the same thing within the first few weeks: is this actually doing anything? The clearest signs wegovy is working are a reduced appetite, feeling full earlier than usual, and gradual, consistent weight loss over weeks rather than days. These shifts are often subtle at first. Wegovy (semaglutide) is a GLP-1 receptor agonist prescribed as part of a medically supervised weight management plan, and it works through biology, not willpower. That means the signals it sends take time to build. It is a prescription-only medicine, so your prescriber is your first port of call if you are unsure how your treatment is going.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The decision most people face in the first month is whether the quiet changes they are noticing count as progress, or whether nothing is happening at all. It is a fair question, and the answer depends on which dose you are on.
Wegovy's dosing schedule starts at 0.25mg weekly, stepping up roughly every four weeks under your prescriber's guidance, with 2.4mg as the established maintenance dose and 7.2mg now approved for some patients. The first pen's job is to settle your system, not to produce dramatic results. That matters because comparing your third week at 0.25mg to someone else's sixth month at 2.4mg will always feel discouraging.
In practice, the signs that the medicine is doing its job at the early stages are functional rather than numerical. You finish your dinner and realise you have left food on the plate. You think about the biscuits in the tin and find the pull is just... quieter. You feel slightly queasy after eating too quickly and learn to slow down. These are not dramatic, but they are real, and they are what the early weeks of Wegovy working typically look like for most people.
Weight loss in the first few weeks is often minimal, particularly if your doses are still increasing. That is normal and expected under the titration schedule set out in the NHS guidance on semaglutide.
Once you have been on a stable dose for a full four-week cycle, you have more to work with. The signs that Wegovy is working at this stage tend to cluster into three areas.
First, appetite regulation. You are eating less not because you are forcing yourself to, but because the urge to eat simply is not as strong. Your prescribers might describe this as a change in food noise. Second, weight movement. Measured weekly at roughly the same time, your weight should be trending downward, even if individual weigh-ins bob up and down. A useful habit: weigh yourself on the same morning every week, before breakfast, rather than checking daily and reacting to normal fluctuation. Third, energy and relationship with food. Some people report that their fixation on eating between meals eases considerably, which makes the lifestyle changes that support treatment feel less like a battle.
If you are exercising alongside treatment, which the evidence strongly supports, our page on Wegovy and working out covers how to combine both without running into common pitfalls. Physical activity does not just aid weight loss, it helps preserve the muscle mass that can be lost during any significant caloric reduction.
The STEP 1 trial, published in the New England Journal of Medicine, found an average body weight reduction of around 15% over 68 weeks at the 2.4mg maintenance dose, alongside lifestyle changes. That average took time and dose escalation to achieve, not four weeks at the starter level.
If you have been on a stable maintenance dose for six weeks and your weight has not moved, your appetite feels unchanged, and the side effects you expected have not appeared, that is not something to sit on. It is the question our clinical team hears most weeks.
A few possibilities are worth considering. Absorption can vary depending on how and when you inject, where you rotate sites, and whether there was a cold-chain break in storage. Dietary intake can creep up to offset the appetite reduction without people realising, keeping a rough food journal for a fortnight often reveals this. Some people genuinely need a higher dose before meaningful effects kick in, which is why the titration schedule exists.
There is a separate, important question about whether Wegovy has stopped working after an initial period of good results. That is a different clinical picture, and it has its own answers, our page on whether Wegovy stops working covers that in detail.
For patients wondering about cost, it is worth noting that Wegovy pricing in the UK varies considerably by provider, and what a headline price includes is not always clear, consultation, aftercare and clinical review matter as much as the medicine itself when you are trying to understand whether treatment is going well.
Ultimately, the question of whether Wegovy is working is a clinical one as much as a personal one. Weight on the scales is one measure; changes in blood pressure, blood sugar, energy and mobility are others. A good prescriber looks at all of these together.
At nume, every repeat order goes through a fresh clinical review before it is approved, a real prescriber reads your update, not software, and that is the conversation where questions like this belong. If you are an existing patient and want to pick up where you left off, you can sign in to your Wegovy account to review your progress or submit an update ahead of your next clinical check. If you are weighing up whether treatment is right for you and have not yet started, or if you are on a different service and want a second opinion, exploring your treatment options is a natural first step.
Wegovy is a prescription medicine. Whether the signs you are seeing are enough, or whether your dose or approach needs revisiting, is a decision made in partnership with a clinician, not alone, and not by comparing your results to someone else's Instagram. Start your free consultation and let our prescribers assess your individual picture.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.